References
- Pirodda A, Brandolini C, Raimondi MC, Ferri GG, Modugno GC, Borghi C. Ménière's disease: update of aetiopathogenetic theories and proposal of a possible model of explanation. Acta Clin Belg. 2010;65:170–5.
- Shibata T, Hibino H, Doi K, Suzuki T, Hisa Y, Kurachi Y. Gastric type H+,K+-ATPase in the cochlear lateral wall is critically involved in formation of the endocochlear potential. Am J Physiol Cell Physiol. 2006;291:1038–48.
- Marcus DC, Wu T, Wangemann P, Kofuji P. KCNJ10 (Kir.4.1) potassium channel knockout abolishes endocochlear potential. Am J Physiol Cell Physiol. 2002;282: 403–7.
- Takeuchi S, Ando M, Kakigi A. Mechanisms generating endocochlear potential: role played by intermediate cells in stria vascularis. Biophys J. 2000;79:2572–82.
- Tranebjaerg L, Bathen J, Tyson J, Bitner-Glindzicz M. Jervell and Lange-Nielsen syndrome: a Norwegian perspective. Am J Med Genet. 1999;89:137–46.
- Pirodda A, Brandolini C, Raimondi MC, Modugno GC, Borghi C. Gastric type proton pump in the inner ear: its possible involvement in labyrinthine disorders. Audiol Med. 2008;6:249–50.
- Pirodda A, Modugno GC, Manzari L, Raimondi MC, Brandolini C, Ferri GG, . Ménière's disease and the use of proton pumps inhibitors. Swiss Med Wkly. 2010;140:w13104.
- Jick H, Wilson A, Wiggins P, Chamberlain DP. Comparison of prescription drug costs in the United States and the United Kingdom, part 2: proton pump inhibitors. Pharmacotherapy. 2012:32:489–92.
- Yamamichi N, Mochizuki S, Asada-Hirayama I, Mikami-Matsuda R, Shimamoto T, Konno-Shimizu M, . Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores. BMC Med. 2012;10:45.
- Chen CL, Orr WC. Autonomic response to heartburn induced by oesophageal acid infusion. J Gastroenterol Hepatol. 2004;19:922–6.
- Lee YC, Wang HP, Lin LY, Lee BC, Chiu HM, Wu MS, . Heart rate variability in patients with different manifestations of gastroesophageal reflux disease. Auton Neurosci. 2004;116:39 45.
- Cuomo R, de Giorgi F, Adinolfi L, Sarnelli G, Loffredo F, Efficie E, . Oesophageal acid exposure and altered neurocardiac function in patients with GERD and idiopathic cardiac dysrhythmias. Aliment Pharmacol Ther. 2006;24: 361–70.
- Degli Esposti D, Raimondi MC, Dormi A, Cosentino ER, Bacchelli S, Brandolini C, . Haemodynamic profile of young subjects with transient tinnitus. Audiol Med. 2009;7: 200–4.
- Wallmark B, Jaresten BM, Larsson H, Ryberg B, Brandstrom A, Fellenius E. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric secretion. Am J Physiol Gastrointest Liver Physiol. 1983;245:64–71.
- Lorentzon P, Eklundh B, Brandstrom A, Wallmark B. The mechanism for inhibition for gastric (H++K+)-ATPase by omeprazole. Biochem Biophys Acta. 1985;817:25–32.
- Metz DC, Vakily M, Dixit T, Mulford D. Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy. Aliment Pharmacol Ther. 2009;29:928–37.
- Naseri E, Yenisehirli A. Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries. Eur J Pharmacol. 2006;531:226–31.
- Yenisehirli A, Naseri E. Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anaesthetized rat. Pharmacol Res. 2008;58:65–71.
- Pirodda A, Brandolini C, Raimondi MC, Modugno GC. The possible role of proton pump inhibitors of the homeostasis of the inner ear. Med Hypotheses. 2009;72:325–6.
- Handa O, Yoshida N, Fujita N, Tanaka Y, Ueda M, Takagi T, . Molecular mechanisms involved in the anti-inflammatory effects of proton pump inhibitors. Inflamm Res. 2006;55:476–80.